Published: 2020-01-28

Near death 18 weeks preeclampsia in molar pregnancy

O. Es Saad, Saloua Tanouti, H. Bkiyar, A. Mimouni, B. Housni


Authors present a case of a molar pregnancy of 18 weeks with preeclampsia complicated with acute pulmonary oedema. A condition carrying a significant risk to mother, therefore, raising an important issue on preeclampsia symptoms on pregnancies before 20 weeks. A 31-year-old woman gravida 2, parity 1 presented with dyspnea at 18 weeks' gestation. Blood pressure was very high (180/110 mmHg) and there was markedly proteinuria (+4). She had severe dyspnea and her oxygen saturation level was 75%. Her chest X-ray graph showed massive acute pulmonary oedema. Ultrasonography shows endometrial cavity containing multiple small cystic spaces, creating a characteristic “snowstorm” and “cluster of grapes” appearance. Markedly elevated quantitative human chorionic gonadotropin (250.000 mIU/mL). The acute pulmonary oedema has been managed by diuretics (Furosemide) and oxygen. There was no cardiac abnormalities in the tranthoracic echocardiogram. Authors administered antihypertensive therapy (intravenous nicardipine and lmethyldopa in per os), and magnesium sulfate in prevention of eclamptic seizures. The pregnancy was terminated by uterine evacuation under oxytocin infusion by manual ultrasound aspiration. She was followed up intensive care unit for two days. Causes of secondary high blood pressure had been eliminated. The patient's blood pressure rapidly normalized two days after delivery. Dyspnea disappeared one day later. Pathologic and cytogenetic analyses revealed a complete hydatiform mole. Two days after delivery; the serum β-hCG level was 99000 mlU/ml. A control ultrasonography shows an empty uterus. Hydatidiform mole is classified into 2 different subtypes, complete hydatidiform mole and partial or incomplete hydatidiform mole development of preeclampsia prior to 20 weeks of gestation should prompt a clinical evaluation to exclude the possibility of an underlying hydatidiform molar pregnancy. Ultrasonography and level of serum BHCG are the initial investigation of choice for the detection of hydatidiform mole. Aspiration is the treatment of reference.


Acute pulmonary oedema, High blood pressure, Molar pregnancy, Ultrasound

Full Text:



Boufettal H, Coullin P, Mahdaoui S, Noun M, Hermas S, Samouh N. Les moles hydatiformes partielles au Maroc: Etude épidémiologique et clinique. EMHJ. 2012;18:755-61.

Cavaliere A, Ermito S, Dinatale A, Pedata R. Management of molar pregnancy. J Prenatal Med. 2009;3:15-7.

Lurain JR, John I. Gestational trophoblastic disease: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010;203:531-9.

Lee C, Smith HO, Kim SJ. Epidemiology. In: Hancock, B.W., Seckl M.J., Berkowitz R.S. and Cole, L.A., Eds., Gestational Trophoblastic Disease, 3rd Edition, ISSTD, McLean; 2009:49-97.

Fouogue TJ, Fouélifack YF, Sando Z, Mboudou ET, Doh AS. Grossesse Molaire et Difficultés de Prise en Charge en Milieu Rural: Illustration d’un Cas Clinique à l’Hopital de District de Bogo (Extrême-Nord Cameroun). Clinics in Mother and Child Health, 2011:8.

Zulvayanti, Krisnadi SR, Achadiyani. Correlation between three pregnancy characteristics (age, parity, βhCG Level) and immunoexpression on complete hydatidiform mole. Open Access Library J. 2017;4:e3634.

Anisodowleh N, Farahnaz K, Nasrin J, Maryam H, Elaheh B. Thyroid hormone levels and its relationship with human chorionic gonadotropin in patients with hydatidiform mole. Open J Obstet Gynecol. 2016;6:56-63.

Chu MM, Ma Y, Tse KY, Chan KK. Cyclophosphamide, hydroxyurea, actinomycin d, methotrexate, and vincristine in the treatment of gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2015;25:498-503.

Beillat T, Dreyfus M. Hypertension artérielle et grossesse. Traité d’obstétrique, Elsevier Masson. 2010:216-225.

Rijhsinghani A, Yankowitz J, Strauss RA, Kuller RA, Patil S, Williamson RA. Risk of preeclampsia in second-trimester triploid pregnancies. Obstet Gynecol. 1997;90:884-8.

Igwegbe AO, Eleje GU. Hydatidiform mole: a review of management outcomes in a tertiary hospital in South-East Nigeria. Ann Med Health Sci Res. 2013;3:210-4.

Kanter D, Marshall DL, Wang ER, Borromeo E, Ananthkarumanchi S, Stillman IE. Angiogenic Dysfunction in Molar Pregnancy. Am J Obstetr Gynecol. 2010;202:184e1-184.e5.

Lam C, Lim KH, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hyper. 2005;46:1077-85.

Igwegbe AO, Eleje GU. Hydatidiform mole: a review of management outcomes in a tertiary hospital in south-east Nigeria. Annals Med Health Sci Res. 2013;3(2):210.

Kim S. Epidemiology. In: Hancock BW, Newlands ES, Berkowitz RS editors. Gestational Trophoblastic Disease. London: Chapman and Hall; 1997:27-42.

Berkowitz RS, Tuncer ZS, Bernstein MR, Goldstein DP. Management of gestational trophoblastic disease: subsequent pregnancy experience. Semin Oncol. 2000;27:678-85.

Matsui H, Iitsuka Y, Suzuka K, Seki S, Sekiya S. Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidiform mole: comparison between complete and partial mole. Hum Reprod. 2001;16:1274-12.